Banka Bioloo Ltd. · NSE:BANKA
Banka Bioloo — Q1 FY2026-27 Earnings Presentation
12 slides from Banka Bioloo's earnings presentation, Aug 13, 2026
Slide 1: Cover letter to NSE: Investor Presentation Q1 FY2026-27
BANKA BIOLOO LIMITED Registered Office: A-109 Express Apartments, Lakdi ka Pool, Hyderabad - 500004 Corporate Office: 5th floor, Prestige Phoenix, 1405, Uma Nagar, Begumpet, Hyderabad - 500016 +91 8688825013 • [email protected] • www.bankabio.com • CIN: L90001TG2012PLC082811 An ISO 9001-2015-14001-2
Slide 2: Investor Presentation Quarter 1, FY 2026–27
Investor Presentation Quarter 1, FY 2026–27 Safe Harbour: This presentation contains forward-looking statements subject to risks and uncertainties; actual results may differ materially. It does not constitute an offer or invitation to purchase securities. BANKA BIOLOO LIMITED | Q1 FY26-27 Investor P
Slide 3: Safe Harbour
Safe Harbour Disclaimer — forward-looking statements and permitted use of this presentation • This presentation and the accompanying slides (the “Presentation”), prepared by Banka Bioloo Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, reco
Slide 4: The Wastewater & Sanitation Crisis
The Wastewater & Sanitation Crisis The opportunity — scale of the sanitation and water-reuse gap Banka Bioloo addresses Untreated wastewater The majority of sewage in fast-urbanising cities is discharged without treatment, polluting rivers and groundwater. 3 Billion people worldwide face inadequate
Slide 5: Impact at a Glance
Impact at a Glance Scale and reach across sanitation, water treatment and railway operations 25,000+ 25,000+ >12 MLD Bio-toilet units deployed Railways systems serviced daily Faecal sludge treated >4 BLD 650+ 7 zones · 26 states Used water treated Employees on roll Pan-India presence Our impact. We
Slide 6: Partial Client List
Partial Client List Trusted by railways, government bodies, Grade-A developers and industrial clients across India BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential — Not for Circulation
Slide 7: Business Overview
Business Overview Banka BioLoo Limited delivers innovation in water, sanitation and hygiene (WaSH) through two focused business lines. Banka Rail Banka WaSH • AMOC — bio-toilet operations & maintenance • EPC in urban water & wastewater • POH — periodic overhauling & bogie upgradation • O&M / BOOT fo
Slide 8: Order Book & Outlook
Order Book & Outlook Order booking and unexecuted order book by segment — Q1 FY26-27 actual (₹ Cr) Order Book — Q1 FY26-27 Actual (₹ Cr) Notable Wins 82 • Won an order with Auro Infra - Hyderabad • We expanded into Bangalore and Mumbai, winning projects with Brigade, Reliance and RMZ. • We secured m
Slide 9: Financial Performance
Financial Performance Quarter 1, FY 2026–27 — Standalone, figures in ₹ Lakhs unless noted Revenue, EBITDA & PAT — Q1 FY25-26 vs Q1 FY26-27 (₹ Lakhs) Revenue (left axis) EBITDA (right axis) PAT (right axis) 2,000 1,800 151 160 1,640 1,600 140 1,361 1,400 120 1,200 103 100 1,000 80 800 60 600 37 400 4
Slide 10: Megaliter Varunaa: Scaling a Long-Term Water Infrastructure Portfolio
Megaliter Varunaa: Scaling a Long-Term Water Infrastructure Portfolio Portfolio has compounded rapidly across projects, treatment capacity and long-term contracted value Megaliter Growth — Cumulative Plants, Treatment Capacity & Net LTV (2022–2026) Cum. Plant (nos.) Cum. Treatment Capacity (MLD) Cum
Slide 11: How Megaliter will drive growth in the long-term
SUMMARY How Megaliter will drive growth in the long-term • Consolidated financials includes revenue from the subsidiary Megaliter Varunaa Pvt limited as per Ind As 110. • Life Time Value (LTV) of Megaliter Varunaa Private Limited is ₹122 Cr, has significant long-term growth potential supported by it
Slide 12: Thank You
Thank You WEBSITE www.bankabio.com CONTACT PERSON Ms. Manjula · [email protected] PHONE +91 7780301502 | +91 8688825013 CORPORATE OFFICE 5th Floor, Prestige Phoenix, Begumpet, Hyderabad – 500016 Safe Harbour: This presentation contains forward-looking statements subject to risks and uncertainties; act